Secondary outcomes, which assessed the efficacy of antibiotic treatment in the short ... 15 children who received initial treatment with co-amoxiclav; three patients experienced minor adverse ...

To examine the impact on antibiotic resistance of early co-amoxiclav use in ‘at risk’ children with influenza/ILI. • To determine the impact on long-term respiratory bacterial carriage of early ...

The Trust’s antibiotic policy recommends co-amoxiclav as first line treatment and ceftriaxone plus metronidazole if there are concerns about concurrent intracranial infection. We aimed to review the ...

or who were to be prescribed antibiotics for infection were excluded. 4809 women (mean age 28 y) were studied after exclusion of 15 women for protocol violations and 2 women for loss to follow up.

Thirty-seven patients were admitted The median age was 84 years (range 52–101 years). Fifty-one percent were male. Eleven (30%) patients were prescribed an antibiotic. Co-amoxiclav and Ciprofloxacin ...

from each CCG’s 2013/14 value Reduction in the proportion of broad spectrum antibiotics (number of co-amoxiclav, cephalosporins and quinolones as a percentage of the total number of selected ...

Analysis of continuous scores and antibiotic effects was carried out separately for women in PROM and SPL groups and reported in their four factorial groups (table 1). Attainment scores in English, ...

The Deputy Director General of Health Services, Dr. G. Wijesooriya emphasized that the samples of the relevant antibiotic named ‘Co- Amoxiclav’ have also been sent to Australia for onward ...

The patient was managed with intravenous co-amoxiclav initially before switching to oral antibiotics, however, represented 1 week later with similar symptoms. Her antibiotic coverage was broadened to ...